Curasight A/S ("Curasight" or "the Company" – TICKER: CURAS), a clinical-stage radiopharmaceutical company developing first-in-class drug candidate uTREAT® targeting uPAR (urokinase-type plasminogen ...
Punjab Chief Minister Maryam Nawaz announces stroke centres in every district and digital honorarium cards for prayer leaders ...
LAHORE: Chief Minister Punjab Maryam Nawaz Sharif has approved the establishment of stroke centers across the province, ...
"Every patient should have access to emergency medical facilities at the nearest hospital," says Punjab CM Maryam Nawaz.
Punjab to set up stroke centres in every district, ensuring timely treatment and trained specialists for emergency care.
Targeted adjunctive intracoronary delivery of the low-dose recombinant tissue plasminogen activator alteplase does not improve microvascular obstruction or major adverse cardiovascular events (MACE) ...
A new research paper was published in Volume 17, Issue 9 of Aging-US on September 11, 2025, titled "Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice." In this ...
PHILADELPHIA -- Current anticoagulant or antiplatelet use is not necessarily a contraindication for administering tissue plasminogen activator (tPA) to a stroke patient in the emergency department, a ...
tPA, initially for stroke, is used in ophthalmology for intraocular fibrin management, especially in severe acute uveitis cases. At Shiley Eye Institute, tPA rapidly dissolves fibrin clots, improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback